Porous Bone Substitute Material with Elastomer Matrix
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current bone substitute materials fail to effectively combine osteoconduction and osteoinduction properties with controlled biodegradability, making them inadequate for restoring large bone defects and promoting complete bone regeneration.
Innovation Solution
A porous bone substitute material comprising a porous elastomer matrix and decellularized bone particles, which provides mechanical stability, biocompatibility, and controlled biodegradability, allowing for osteoprogenitor cell adhesion, proliferation, and differentiation into osteoblasts.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional bone substitute materials (ceramics, hydroxyapatite, tricalcium phosphates) are used, then osteoconduction is provided, but osteoinduction and controlled biodegradability are insufficient
Solution Approach 1:
The invention combines decellularized bone particles (providing osteoinduction through growth factors and osteoconduction through mineral matrix) with a porous elastomer matrix ( providing mechanical stability and controlled biodegradability). This composite structure integrates multiple functions that conventional single-material substitutes cannot achieve simultaneously.
Solution Approach 2:
The material exhibits different properties in different phases: the decellularized bone particles provide biological activity (osteoinduction and osteoconduction) while the elastomer matrix provides mechanical support and controlled degradation. This spatial differentiation of functions resolves the contradiction between biological effectiveness and mechanical stability.
2Reliability
If autologous bone graft is used, then biological compatibility is achieved, but cell death in transplanted tissue and requirement for two surgical sites occur
Solution Approach 1:
The invention uses decellularized bone particles as a biological copy that retains the essential osteoinductive and osteoconductive properties of natural bone without the harmful aspects. The decellularization process removes cells (avoiding cell death issues) while preserving the extracellular matrix and growth factors that drive bone regeneration.
Solution Approach 2:
The decellularized bone particles act as an intermediary between the patient's own bone regeneration capacity and the implant site. They provide the biological signals needed for osteogenesis without requiring harvesting from another site, thus eliminating the need for two surgical procedures.
3Quantity of substance
If allogeneic bone graft is used, then bone substance is replaced, but immune response and limited availability occur
Solution Approach 1:
The decellularization process converts what would be harmful cellular components (potential sources of immune rejection in allogeneic grafts) into benefits by removing them entirely. The resulting acellular matrix provides structural support and growth factor reservoirs without triggering immune responses, while still delivering osteoinductive signals.
4Reliability
If porous structure is implemented, then vascularization and cell proliferation are promoted, but mechanical strength may be reduced
Solution Approach 1:
The elastomer matrix provides a flexible, porous framework that maintains mechanical integrity while allowing vascular infiltration and cell migration. The elastomeric nature allows the material to accommodate structural requirements for strength while the porosity enables biological functions like vascularization and nutrient transport.
Data Source
AI summary
The present invention relates to a porous bone substitution material for bone repair, in particular the repair of a cavitary bone defect and/or the repair of a segmental bone defect.